Results 271 to 280 of about 366,264 (296)
Some of the next articles are maybe not open access.
[Epidemiology of drug-resistant epilepsies].
Revue neurologique, 2004To evaluate the incidence and the prevalence of drug-resistant epilepsies and risk factors in relation with this condition.The epidemiological approach of drug-resistant epilepsies come up against two major difficulties: the lack of a rigorous and consensus definition of this condition and its elusive evaluation which is indirectly appreciated with ...
openaire +1 more source
Ciprofloxacin for treatment of drug-resistant epilepsy.
Epilepsy Research, 2021H. Cheraghmakani +7 more
semanticscholar +1 more source
Transcutaneous vagus nerve stimulation in the treatment of drug-resistant epilepsy.
Autonomic Neuroscience: Basic & Clinical, 2021R. von Wrede, R. Surges
semanticscholar +1 more source
Surgical Treatment for Drug-Resistant Epilepsy
JAMA, 2015Juan, Gomez-Alonso, Paula, Bellas-Lamas
openaire +2 more sources
[Evaluation of drug-resistant epilepsy].
Revista de neurologia, 2000Drug-resistant epilepsy makes up between 10 and 30% of all epilepsies, and is an important cause of morbidity and mortality. In this article we review the guidelines and techniques used when assessing a patient with drug-resistant epilepsy.Evaluation of a patient with drug-resistant epilepsy requires three steps: first a careful, detailed clinical ...
openaire +1 more source
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies
Ca-A Cancer Journal for Clinicians, 2022Paolo Tarantino +2 more
exaly
[Apparent drug resistance in epilepsy].
Deutsche medizinische Wochenschrift (1946), 1991To elucidate possible sources of error in the assessment of drug-resistant epilepsy questionnaires were sent, at least one year after hospital discharge, to 259 patients hospitalized between 1. 1. and 31. 12. 1986 because of epilepsy. Information thus obtained included whether and what seizures had occurred after discharge and what drugs had been taken.
openaire +1 more source
Clinical development of novel therapeutics for castration‐resistant prostate cancer
Ca-A Cancer Journal for Clinicians, 2012William K Oh
exaly

